Wacker Chemie Ag · XETR:WCH

Wacker Chemie — Non-Deal Roadshow (March 2022)

13 slides from Wacker Chemie's roadshow presentation, Mar 15, 2022

  1. Slide 1: WACKER – Cash, Growth and Sustainability

    CREATING TOMORROW`S SOLUTIONS WACKER – Cash, Growth and Sustainability Wacker Chemie AG March 15, 2022 Ticker: WCH © Wacker Chemie AG www.wacker.com March 15, 2022 0

  2. Slide 2: Disclaimer

    Disclaimer The information contained in this presentation is for background purposes only and is subject to amendment, revision and updating. Certain statements and information contained in this presentation may relate to future expectations and other forward-looking statements that are based on man

  3. Slide 3: WACKER: At a Glance

    WACKER: At a Glance Facts & Figures POLYSILICON SILICONES No. 1 in semi No. 2 €1.54bn 14,400 EBITDA in 2021 Employees €6.21bn 26 Sales Sales in 2021 Production Sites FY 2021 24.8% 23 EBITDA margin Technical Centers POLYMERS in 2021 No. 1 Business Scientific OTHERS 4 Segments 45 collaborations BIOSOL

  4. Slide 4: SILICONES: At a Glance

    SILICONES: At a Glance Full Portfolio Supplier with Silicones: a Basis for Financial Performance Focus on Specialties Unlimited Applications 21% 20% €555m €460m 13% Downstream specialty business: Broad range of adjustable properties:  Customization, innovation,  Hydrophobic / hydrophilic, adhesive

  5. Slide 5: POLYMERS: At a Glance

    POLYMERS: At a Glance Global Presence with Creating Value in a Wide Financial Performance Tandem Sites (DPP + VAE)1 Range of Applications 17% 15% 15% €255m €215m €155m  Serving customers in all key markets  Value-based substitution  Addressing individual regional  Enable smart construction marke

  6. Slide 6: BIOSOLUTIONS: At a Glance

    BIOSOLUTIONS: At a Glance Accelerated Growth in Focus on Efficiency & Cash New 2030 Ambition BioPharma & BioIngredients in Life Science Chemicals €1bn Sales in BIOSOLUTIONS with >25% BioPharma: Gum: EBITDA by 2030  GMP contract manufacturing of  Food-grade polyvinyl acetate biologics, vaccines, li

  7. Slide 7: POLYSILICON: At a Glance

    POLYSILICON: At a Glance Benchmark Quality for Semi Aggressive Cost Reductions Financial Performance and Solar Grade Polysilicon at all Sites 42% 43% €655m €470m  Specialty strategy with Clear #1 15%  Successful execution of cost market position in semiconductor roadmap & targets polysilicon €140m

  8. Slide 8: Setting New and More Ambitious Sustainability Targets for 2030

    Setting New and More Ambitious Sustainability Targets for 2030 Value Up Footprint Down Collaboration Beyond Reduction in absolute GHG1 100% Products meet sustainability criteria 50% emissions (vs. 2020) 100% Key suppliers meet sustainability standards Reduction in absolute Reduction in specific wate

  9. Slide 9: Guidance FY 2022

    Guidance FY 2022 In €m FY 2021 Outlook 2022 Sales 6,208 Around €7,000m EBITDA 1,539 €1,200 – 1,500m EBITDA margin (%) 24.8% Substantially lower than last year Net cash flow 761 Clearly positive, substantially lower than last year CapEx 344 €550 – 600m Net financial debt -547 Positive net financial a

  10. Slide 10: Q1 Trading Update

    Q1 Trading Update Sales of about €2bn with EBITDA Rising More Strongly than Sales Y/Y SILICONES POLYMERS  Continued strong growth  Continued strong growth  First months of 2022 still benefit from trailing raw  Prices higher than PY to compensate for higher raws material prices and energy hedging

  11. Slide 11: FY 2021 Results – Breakdown by Business

    Appendix: FY 2021 Results – Breakdown by Business FY 2021 FY 2020 Q4 2021 Q4 2020 EBITDA EBITDA EBITDA EBITDA In €m / % SALES EBITDA MARGIN SALES EBITDA MARGIN SALES EBITDA MARGIN SALES EBITDA MARGIN Chemicals 4,569 844 18.5% 3,789 696 18.4% 1,188 213 17.9% 966 181 18.8% SILICONES 2,599 553 21.3% 2,

  12. Slide 12: Raw Materials, Power and Gas Show Strong Price Inflation

    Appendix: Raw Materials, Power and Gas Show Strong Price Inflation Si-Metal (€/mt) Electricity (€/MWh) 10,000 400 8,200 € High 380 € High 8,000 300 6,000 200 4,000 100 2,000 0 0 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Source: CRU, Si-Metal

  13. Slide 13: WACKER: Issuer, Contact and Additional Information

    WACKER: Issuer, Contact and Additional Information Issuer and Contact Financial Calendar INVESTOR RELATIONS CONTACTS 03/29/22 CMD: Strategy Update (London) 04/28/22 Q1 2022 Results Joerg Hoffmann, CFA Tel. +49 89 6279 1633 | joerg.hoffmann@wacker.com 05/20/22 Annual General Meeting 07/28/22 Q2 2022

Wacker Chemie — Non-Deal Roadshow (March 2022) on 6ix